Cargando…
Carborane-based design of a potent vitamin D receptor agonist
The vitamin D nuclear receptor (VDR) is a potential target for cancer therapy. It is expressed in many tumors and its ligand shows anticancer actions. To combine these properties with the application of boron neutron capture therapy (BNCT), we design and synthesize a potent VDR agonist based on the...
Autores principales: | Otero, Rocio, Seoane, Samuel, Sigüeiro, Rita, Belorusova, Anna Y., Maestro, Miguel A., Pérez-Fernández, Roman, Rochel, Natacha, Mouriño, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531031/ https://www.ncbi.nlm.nih.gov/pubmed/28808527 http://dx.doi.org/10.1039/c5sc03084f |
Ejemplares similares
-
1α,25(OH)(2)-3-Epi-Vitamin D(3), a Natural Physiological Metabolite of Vitamin D(3): Its Synthesis, Biological Activity and Crystal Structure with Its Receptor
por: Molnár, Ferdinand, et al.
Publicado: (2011) -
Vitamin D Analogs Bearing C-20 Modifications Stabilize the Agonistic Conformation of Non-Responsive Vitamin D Receptor Variants
por: Belorusova, Anna Y., et al.
Publicado: (2022) -
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment
por: Seoane, Samuel, et al.
Publicado: (2015) -
Design, Synthesis, Evaluation and Structure of Allenic 1α,25‐Dihydroxyvitamin D(3) Analogs with Locked Mobility at C‐17
por: Fraga, Ramón, et al.
Publicado: (2021) -
Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia
por: Rovito, Daniela, et al.
Publicado: (2020)